In addition, high mTOR expression was associated with a poor prognosis in several human cancers, including renal cell cancer, lung cancer, breast cancer, laryngeal squamous cell carcinoma, neuroendocrine tumors, biliary tract adenocarcinoma, and colorectal cancers [6]–[10]. This evidence concerns the gene MTOR and lung cancer.